← SynDRA
OZAGREL
SynDRA canonical compound SYN0000518 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | TBXAS1 |
| Mechanism of action | thromboxane synthase inhibitor |
| Indication | stroke |
| Disease area | neurology/psychiatry |
All known targets
Mechanisms of action (all sources)
- TBXAS1 INHIBITOR
- Thromboxane-A synthase inhibitor
- thromboxane synthase inhibitor
- MAPK14 INHIBITOR
Drug classes
- Cardiovascular Agents
- Enzyme Inhibitors
- Fibrinolytic Agents
- Hematologic Agents
- Histamine Agents
- Histamine Antagonists
- Neurotransmitter Agents
Cross-references
Synonyms
- ozagrel sodium
- sodium ozagrel
- xanbon
- ozagrel hydrochloride
- ozagrel hydrochloride hydrate
- domenan
- pulmoza
- OKY-046
- ozagrel HCl
- KCT-0809
- Ozagrel (ophthalmic, eye disorders)
- Ozagrel (ophthalmic, eye disorders), Kissei/ Teika
- Ozagrelum
- L256JB984D
- (2E)-3-{4-[(1H-imidazol-1-yl)methyl]phenyl}prop-2-enoic acid
- 3-(4-(imidazol-1-ylmethyl)phenyl)prop-2-enoic acid
- 3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid
- (2E)-3-(4-((1H-imidazol-1-yl)methyl)phenyl)prop-2-enoic acid
- 4-(1-imidazoylmethyl)cinnamic acid
- RefChem:169192
- 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-2-propenoic acid
- DTXCID6028103
- Cataclot
- Ozagrel [INN]
- (E)-3-(4-((1H-IMIDAZOL-1-YL)METHYL)PHENYL)ACRYLIC ACID
- MFCD00868231
- (E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid
- (E)-p-(Imidazol-1-ylmethyl)cinnamic acid
- Ozagrel (INN)
- Ozagrelum [Latin]
- Ozagrel free acid
- (E)-3-[4-[(1H-Imidazol-1-yl)methyl]phenyl]acrylic Acid
- UNII-L256JB984D
- Cataclot (TN)
- OZAGREL [MI]
- 3-[4-(1-imidazolylmethyl)phenyl]-2-propenoic acid
- OZAGREL [MART.]
- Prestwick2_000979
Look up OZAGREL in the interactive SynDRA portal →